ARG2 and prostate carcinoma: A detailed investigation of the gene expression relationship between CD38 and ARG2 demonstrated Boolean relationship “CD38 high => ARG2 high” (Figure 2A) and three possible groupings of prostate cancer cases: CD38+ARG2+, CD38-ARG2+, and CD38-ARG2- (Figure 2B).